Lataa...
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Before it was molecularly cloned in 1994, acute-phase response factor or signal transducer and activator of transcription (STAT)3 was the focus of intense research into understanding the mammalian response to injury, particularly the acute-phase response. Although known to be essential for liver pro...
Tallennettuna:
| Julkaisussa: | Pharmacol Rev |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The American Society for Pharmacology and Experimental Therapeutics
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7300325/ https://ncbi.nlm.nih.gov/pubmed/32198236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/pr.119.018440 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|